CoreWeave shares have plunged 61% from a $187 peak to around $69, wiping out $33 billion in value in six weeks. Investors are ...

The organization, which published four distinct goals and a call to action while gathering hundreds of signatories, hopes to ...

The significance of the survey findings lies not only in today's picture but in what these shifts signal about the direction of workplace transformation. The workplace ahead will be defined less by ...

U.S. Treasuries seem increasingly anxious about 2026 and the bond market is already rebuilding risk premia ahead of the new ...

HSAs appear preferable to other tax-advantaged savings vehicles, especially for investors expecting out-of-pocket healthcare ...

Proteins, peptides, and pills, oh my! In 2025, NFL players, silver screen superheroes, and creators told us all about ...

The FDA approved Addyi for post-menopausal women. The drugmaker’s CEO Cindy Eckert explains why it matters.

Without clear limits, it also risks narrowing minds and weakening the social skills that childhood should build. Artificial ...

Ford Motor to take big EV charge, Bitcoin dips below $86,000, Trump forms Tech Force, and more news to start your day.

Morning Brief host Julie Hyman breaks down the biggest market stories developing on December 16, 2025. RSM chief economist ...

The S&P 500 fell for a third straight day. Treasury yields edged mildly down as swaps implied only 20% odds of a January Fed ...

Over the last few years, artificial intelligence (AI) has become extremely popular in Silicon Valley and is widely regarded ...